Sonic Healthcare Limited (ASX:SHL)
Australia flag Australia · Delayed Price · Currency is AUD
20.06
-0.38 (-1.86%)
Aug 26, 2026, 4:18 PM AEST

Sonic Healthcare Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Sonic Healthcare stock has a consensus rating of "Hold" and an average price target of $22.51. The average 1-year stock price forecast is 12.21% higher than the current stock price, while the lowest is $19.60 (-2.29%) and the highest is $27.50 (+37.09%).

Price Target: $22.51 (+12.21%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$19.60$22.51$22.20$27.50
Change-2.29%+12.21%+10.67%+37.09%

Analyst Ratings

The average analyst rating for Sonic Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy555644
Buy111011
Hold876788
Sell011111
Strong Sell112222
Total151515161616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jarden
Jarden
Hold
Maintains
$22.30$22.90
HoldMaintains$22.30$22.90+14.16%Aug 22, 2026
Citi
Citi
Hold
Maintains
$19.00
HoldMaintains$19.00-5.28%Aug 21, 2026
Morgan Stanley
Morgan Stanley
Sell
Maintains
$20.60
SellMaintains$20.60+2.69%Aug 21, 2026
Morgans
Morgans
Hold
Downgrades
$22.40
HoldDowngrades$22.40+11.67%Aug 21, 2026
Unknown Analyst
Ord Minnett
No rating
Ord Minnett
Hold
Maintains
$21.50$20.80
HoldMaintains$21.50$20.80+3.69%Aug 21, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
11.11B
from 10.87B
Increased by 2.23%
Revenue Next Year
11.58B
from 11.11B
Increased by 4.21%
EPS This Year
1.22
from 1.26
Decreased by -2.92%
EPS Next Year
1.31
from 1.22
Increased by 7.76%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
9.34B8.17B8.97B9.65B10.87B11.11B
Revenue Growth
6.69%-12.54%9.77%7.56%12.67%2.23%
Gross Profit
3.73B2.84B2.94B3.19B3.58B3.91B
Gross Margin
39.89%34.80%32.84%33.05%32.99%35.20%
Operating Income
2.16B1.02B849.66M936.19M1.00B1.06B
Net Income
1.46B684.98M511.09M513.60M608.29M595.20M
EPS
----1.261.22
EPS Growth
----17.71%-2.92%
Forward PE
15.8122.9423.5421.6616.0616.45
Dividend / Share
1.001.041.061.071.081.07
Dividend Growth
9.89%4.00%1.92%0.94%0.94%-0.84%
Free Cash Flow
1.55B786.04M418.20M725.20M736.21M1.03B
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202720282029
High11.4B
Avg11.1B
Low10.9B

Revenue Growth

Revenue Growth202720282029
High
5.2%
Avg
2.2%
Low
0.4%

EPS Forecast

EPS202720282029
High1.38
Avg1.22
Low1.12

EPS Growth

EPS Growth202720282029
High
9.7%
Avg
-2.9%
Low
-10.8%